Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | GSK-J4 |
Synonyms | |
Therapy Description |
GSK-J4 is a specific inhibitor of KDM6, which results in increased H3K27 tri-methylation and induction of DNA damage response and cell death (PMID: 22842901, PMID: 26759175, PMID: 32525734, PMID: 32477122, PMID: 32514253). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
GSK-J4 | GSK-J4 is a specific inhibitor of KDM6, which results in increased H3K27 tri-methylation and induction of DNA damage response and cell death (PMID: 22842901, PMID: 26759175, PMID: 32525734, PMID: 32477122, PMID: 32514253). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|